James F. Reddoch, EVP & Chief Scientific Officer at Royalty Pharma plc (RPRX), sold 75,000 shares at $40.44 ($3.0M) on 2022-05-19, disclosed to the SEC on 2022-05-23.
Open-market sale of $3.0M RPRX by EVP & Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| RPRX | SELL | 2022-05-31 | $3.1M | — | Filing → |
| RPRX | SELL | 2021-07-27 | $712K | — | Filing → |
| RPRX | SELL | 2021-07-14 | $1.5M | — | Filing → |